Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis.

about

Radioimmunotherapy-based conditioning regimen prior to autologous stem cell transplantation in non-Hodgkin lymphoma

P2860

Q57301219-766F8722-DBF3-43B0-949A-7BAA76204CBC

P2860

Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q38576523

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Randomized controlled trials i ...... atic review and meta-analysis.

@en

type

Item

label

Randomized controlled trials i ...... atic review and meta-analysis.

@en

prefLabel

Randomized controlled trials i ...... atic review and meta-analysis.

@en

P1476

Randomized controlled trials i ...... atic review and meta-analysis.

@en

P2093

Ann Colosia

http://www.w3.org/2001/XMLSchema#string

Annete Njue

http://www.w3.org/2001/XMLSchema#string

Beth Sherril

http://www.w3.org/2001/XMLSchema#string

James A Kaye

http://www.w3.org/2001/XMLSchema#string

Jianmin Wang

http://www.w3.org/2001/XMLSchema#string

Mehdi Hamadani

http://www.w3.org/2001/XMLSchema#string

Peter C Trask

http://www.w3.org/2001/XMLSchema#string

Rachel L Police

http://www.w3.org/2001/XMLSchema#string

Robert Olivares

http://www.w3.org/2001/XMLSchema#string

Rodrigo Ruiz-Soto

http://www.w3.org/2001/XMLSchema#string

P2860

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial.

Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.

PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma.

Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study.

Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party.

Follicular lymphoma: current management and future directions.

P304

666-678

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1177/1078155215603230

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Adeline Abbé

P577

2015-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26320127

http://www.w3.org/2001/XMLSchema#string

Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis.

about

P2860

P2860

Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698